{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:13:57Z","timestamp":1790522037723,"version":"4.1.0"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1888,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1111\/j.1526-4637.2010.00877.x","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T18:16:16Z","timestamp":1276020976000},"page":"1078-1091","source":"Crossref","is-referenced-by-count":73,"title":["Post-marketing Surveillance of Methadone and Buprenorphine in the United States"],"prefix":"10.1093","volume":"11","author":[{"given":"Nabarun","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise J.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Inciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Parrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Dart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"2016030722541591000_11.7.1078.1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1276"},{"key":"2016030722541591000_11.7.1078.2","unstructured":"Sanford K . Findings and Recommendations of the Task Force to Prevent Deaths from Unintentional Drug Overdoses in North Carolina, 2003. N.C. Injury and Violence Prevention Branch\u2014North Carolina Department of Health and Human Services, Editor; 2004. Available at: http:\/\/www.ncpublichealth.com (accessed December 2008)."},{"key":"2016030722541591000_11.7.1078.3","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770280111012"},{"key":"2016030722541591000_11.7.1078.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1947.02890140008003"},{"key":"2016030722541591000_11.7.1078.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.02.012"},{"issue":"7","key":"2016030722541591000_11.7.1078.6","first-page":"127","article-title":"The diversion of prescription opioid analgesics","volume":"7","author":"Inciardi","year":"2007","journal-title":"Law Enforc Exec Forum"},{"issue":"194","key":"2016030722541591000_11.7.1078.7","first-page":"62354","article-title":"Schedules of controlled substances: Rescheduling of buprenorphine from schedule V to schedule III","volume":"67","author":"Drug Enforcement Agency","year":"2002","journal-title":"Fed Regist"},{"key":"2016030722541591000_11.7.1078.8","unstructured":"Food and Drug Administration. FDA Public Health Advisory, Methadone Use for Pain Control May Result in Death and Life-Threatening Changes in Breathing and Heart Beat. Bethesda, MD: Center for Drug Evaluation and Research; 2007."},{"key":"2016030722541591000_11.7.1078.9","unstructured":"Drug Enforcement Agency. Methadone Hydrochloride Tablets USP 40 mg (Dispersible). Available at: http:\/\/www.deadiversion.usdoj.gov\/pubs\/pressrel\/methadone_advisory.htm 2007 (accessed March 2009)."},{"issue":"6","key":"2016030722541591000_11.7.1078.10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1331\/JAPhA.2009.08102","article-title":"National study of medications associated with injury in elderly Medicare\/Medicaid dual enrollees during 2003","volume":"49","author":"Blackwell","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"2016030722541591000_11.7.1078.11","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1901"},{"key":"2016030722541591000_11.7.1078.12","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802010892"},{"key":"2016030722541591000_11.7.1078.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.802"},{"key":"2016030722541591000_11.7.1078.14","first-page":"4","article-title":"An Unrelenting Epidemic of Deaths from Prescription Drugs in North Carolina","volume":"2","author":"Sanford","year":"2008","journal-title":"Forum (North Carolina Medical Board)"},{"key":"2016030722541591000_11.7.1078.15","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802544938"},{"key":"2016030722541591000_11.7.1078.16","doi-asserted-by":"crossref","unstructured":"Dunn KM Saunders KW Rutter CM Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 152(2):85\u201392.","DOI":"10.7326\/0003-4819-152-2-201001190-00006"},{"issue":"3","key":"2016030722541591000_11.7.1078.17","first-page":"210","article-title":"Methadone-induced mortality in the treatment of chronic pain: Role of QT prolongation","volume":"16","author":"Andrews","year":"2009","journal-title":"Cardiol J"},{"key":"2016030722541591000_11.7.1078.18","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1112"},{"key":"2016030722541591000_11.7.1078.19","doi-asserted-by":"crossref","unstructured":"Wilford B Maxwell J . Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators. Available at: http:\/\/buprenorphine.samhsa.gov\/Buprenorphine_FinalReport_12.6.06.pdf 2006 (accessed March 2009).","DOI":"10.2165\/00128415-200912570-00036"},{"key":"2016030722541591000_11.7.1078.20","unstructured":"Clark W . Buprenorphine in the treatment of opioid addiction: Balancing medication access with quality care. Paper presented at: SAMSHA Conference; 2008; Washington, DC."},{"key":"2016030722541591000_11.7.1078.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.019"},{"key":"2016030722541591000_11.7.1078.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.01.003"},{"key":"2016030722541591000_11.7.1078.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2004.04001.x"},{"issue":"3","key":"2016030722541591000_11.7.1078.24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5055\/jom.2008.0019","article-title":"Epidemiology of opioid pharmacy claims in the United States","volume":"4","author":"Williams","year":"2008","journal-title":"J Opioid Manag"},{"key":"2016030722541591000_11.7.1078.25","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000228025.04535.25"},{"key":"2016030722541591000_11.7.1078.26","doi-asserted-by":"publisher","DOI":"10.3816\/SCT.2005.n.010"},{"key":"2016030722541591000_11.7.1078.27","doi-asserted-by":"crossref","unstructured":"Mattick RP Breen C Kimber J Davoli M . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;(3):CD002209.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"2016030722541591000_11.7.1078.28","doi-asserted-by":"crossref","unstructured":"Mattick RP Kimber J Breen C Davoli M . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008;(2):CD002207.","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"2016030722541591000_11.7.1078.29","doi-asserted-by":"publisher","DOI":"10.1086\/508184"},{"key":"2016030722541591000_11.7.1078.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01271.x"},{"key":"2016030722541591000_11.7.1078.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.1.45"},{"key":"2016030722541591000_11.7.1078.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.05.021"},{"key":"2016030722541591000_11.7.1078.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02627.x"},{"key":"2016030722541591000_11.7.1078.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02558.x"},{"key":"2016030722541591000_11.7.1078.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02090.x"},{"key":"2016030722541591000_11.7.1078.36","doi-asserted-by":"publisher","DOI":"10.1080\/09595230701373834"},{"key":"2016030722541591000_11.7.1078.37","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000245561.99036.49"},{"key":"2016030722541591000_11.7.1078.38","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-941482"},{"key":"2016030722541591000_11.7.1078.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.12.007"},{"key":"2016030722541591000_11.7.1078.40","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2003.00201.x"},{"key":"2016030722541591000_11.7.1078.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2006.03.037"},{"key":"2016030722541591000_11.7.1078.42","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200625020-00002"},{"key":"2016030722541591000_11.7.1078.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00790.x"},{"key":"2016030722541591000_11.7.1078.44","doi-asserted-by":"publisher","DOI":"10.1002\/hup.698"},{"key":"2016030722541591000_11.7.1078.45","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.430"},{"key":"2016030722541591000_11.7.1078.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2006.00259.x"},{"key":"2016030722541591000_11.7.1078.47","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n02_08"},{"key":"2016030722541591000_11.7.1078.48","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1113"},{"key":"2016030722541591000_11.7.1078.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.05.004"},{"key":"2016030722541591000_11.7.1078.50","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1452"},{"key":"2016030722541591000_11.7.1078.51","unstructured":"American Association of Poison Control Centers National Poison Data System (NPDS). NPDS Reference Manual. 2007."},{"key":"2016030722541591000_11.7.1078.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2005.02.036"},{"key":"2016030722541591000_11.7.1078.53","doi-asserted-by":"publisher","DOI":"10.1080\/15563650600981137"},{"key":"2016030722541591000_11.7.1078.54","doi-asserted-by":"publisher","DOI":"10.1080\/00952990600753982"},{"key":"2016030722541591000_11.7.1078.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.01.011"},{"key":"2016030722541591000_11.7.1078.56","doi-asserted-by":"publisher","DOI":"10.1080\/15563650600956170"},{"key":"2016030722541591000_11.7.1078.57","unstructured":"Department of Health and Human Services. Certification of opioid treatment programs, in 42 CFR, Section 8. G.P. Office, Editor. 2002."},{"key":"2016030722541591000_11.7.1078.58","unstructured":"Department of Justice. Drug abuse prevention and control, in 21 CFR, Chapter 13, D.E. Agency, Editor."},{"key":"2016030722541591000_11.7.1078.59","unstructured":"Drug Addiction Treatment Act of 2000. XXXV\u2014Waiver Authority for Physicians who dispense or prescribe certain narcotic drugs for maintenance treatment or detoxification treatment, in Public Law 106-310. 2000."},{"key":"2016030722541591000_11.7.1078.60","unstructured":"Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Department of Health and Human Services; 2006."},{"key":"2016030722541591000_11.7.1078.61","unstructured":"Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Department of Health and Human Services; 2008."},{"key":"2016030722541591000_11.7.1078.62","doi-asserted-by":"publisher","DOI":"10.1159\/000149631"},{"key":"2016030722541591000_11.7.1078.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01767.x"},{"key":"2016030722541591000_11.7.1078.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.08.008"},{"key":"2016030722541591000_11.7.1078.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2008.09.007"},{"issue":"6","key":"2016030722541591000_11.7.1078.66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5055\/jom.2007.0018","article-title":"Use and misuse of buprenorphine in the management of opioid addiction","volume":"3","author":"Cicero","year":"2007","journal-title":"J Opioid Manag"},{"key":"2016030722541591000_11.7.1078.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.015"},{"key":"2016030722541591000_11.7.1078.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.11.003"},{"key":"2016030722541591000_11.7.1078.69","doi-asserted-by":"publisher","DOI":"10.1080\/09595230601036986"},{"key":"2016030722541591000_11.7.1078.70","doi-asserted-by":"crossref","unstructured":"Peles E Schreiber S Adelson M . 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend 107(2\u20133):141\u2013148.","DOI":"10.1016\/j.drugalcdep.2009.09.013"},{"key":"2016030722541591000_11.7.1078.71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02025.x"},{"key":"2016030722541591000_11.7.1078.72","doi-asserted-by":"publisher","DOI":"10.1080\/10550880902772373"},{"key":"2016030722541591000_11.7.1078.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2005.09.004"},{"key":"2016030722541591000_11.7.1078.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.07.015"},{"key":"2016030722541591000_11.7.1078.75","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1774"},{"key":"2016030722541591000_11.7.1078.76","doi-asserted-by":"crossref","unstructured":"Letsky MC Zumwalt RE Seifert SA Benson BE . Cause of death conundrum with methadone use: A case report. Am J Forensic Med Pathol 2010 (in press).","DOI":"10.1097\/PAF.0b013e3181d3de94"},{"key":"2016030722541591000_11.7.1078.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2009.12.033"},{"key":"2016030722541591000_11.7.1078.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.10.009"},{"issue":"2","key":"2016030722541591000_11.7.1078.79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3565(25)12294-5","article-title":"Buprenorphine's physical dependence potential: Antagonist-precipitated withdrawal in humans","volume":"276","author":"Eissenberg","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2016030722541591000_11.7.1078.80","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802585406"},{"key":"2016030722541591000_11.7.1078.81","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0023-6"},{"key":"2016030722541591000_11.7.1078.82","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18032"},{"key":"2016030722541591000_11.7.1078.83","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-006-9018-2"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/11\/7\/1078\/5159491\/11-7-1078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:43:36Z","timestamp":1740167016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1111\/j.1526-4637.2010.00877.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":83,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7,1]]},"published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1526-4637.2010.00877.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00877.x","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}